Evidence map›Paper›PMID 38365780›Full record

ArticleNature communications2024

A microfluidic platform integrating functional vascularized organoids-on-chip.

Clément Quintard, Emily Tubbs, Gustav Jonsson, Jie Jiao, Jun Wang, Nicolas Werschler, Camille Laporte, Amandine Pitaval, Thierno-Sidy Bah, Gideon Pomeranz and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 178 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 3 pooled it
43.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 3 syntheses or guidelines pooled it, 238 citations in OpenAlex.

  1. Pooled it
  2. [Organoid-based strategies and challenges in tissue regeneration].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026
    Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  15. Article
  16. Review
  17. Review
  18. Advances in vascularized organoids.Chinese medical journal · 2026
    Review
  19. Review
  20. Review

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 5 countries.

Clément QuintardUniv. Grenoble Alpes, CEA, IRIG/BGE, BIOMICS, 38000, Grenoble, France.
Emily TubbsUniv. Grenoble Alpes, CEA, IRIG/BGE, BIOMICS, 38000, Grenoble, France.
Gustav JonssonInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, IMBA, Dr. Bohr-Gasse 3, 1030, Vienna, Austria.ORCID 0000-0001-6692-8395
Jie JiaoDepartment of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia (BC), Canada.
Jun WangDepartment of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia (BC), Canada.ORCID 0000-0003-2801-4861
Nicolas WerschlerSchool of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia (BC), Canada.ORCID 0000-0003-4860-8587
Camille LaporteUniv. Grenoble Alpes, CEA, IRIG/BGE, BIOMICS, 38000, Grenoble, France.ORCID 0000-0003-1577-3156
Amandine PitavalUniv. Grenoble Alpes, CEA, IRIG/BGE, BIOMICS, 38000, Grenoble, France.
Thierno-Sidy BahUniv. Grenoble Alpes, CEA, IRIG, BGE, Gen&Chem, 38000, Grenoble, France.
Gideon PomeranzDevelopmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.
Caroline BissardonUniv. Grenoble Alpes, CEA, LETI, DTBS, 38000, Grenoble, France.
Joris KaalUniv. Grenoble Alpes, CEA, LETI, DTBS, 38000, Grenoble, France.
Alexandra LeopoldiInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, IMBA, Dr. Bohr-Gasse 3, 1030, Vienna, Austria.
David A LongDevelopmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.ORCID 0000-0001-6580-3435
Pierre BlandinUniv. Grenoble Alpes, CEA, LETI, DTBS, 38000, Grenoble, France.
Jean-Luc AchardUniversité Grenoble Alpes, CNRS, Grenoble INP, LEGI, 38000, Grenoble, France.
Christophe BattailUniv. Grenoble Alpes, CEA, IRIG, BGE, Gen&Chem, 38000, Grenoble, France.ORCID 0000-0001-6849-7824
Astrid HagelkruysInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, IMBA, Dr. Bohr-Gasse 3, 1030, Vienna, Austria.ORCID 0000-0003-3015-4038
Fabrice NavarroUniv. Grenoble Alpes, CEA, LETI, DTBS, 38000, Grenoble, France.
Yves FouilletUniv. Grenoble Alpes, CEA, LETI, DTBS, 38000, Grenoble, France.
Josef M PenningerDepartment of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia (BC), Canada. josef.penninger@ubc.ca.ORCID 0000-0002-8194-3777
Xavier GidrolUniv. Grenoble Alpes, CEA, IRIG/BGE, BIOMICS, 38000, Grenoble, France. xavier.gidrol@cea.fr.ORCID 0000-0002-4233-3749
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstitute of Molecular Biotechnology · ATUniversity of British Columbia · CAGreat Ormond Street Hospital · GBInstitut polytechnique de Grenoble · FR

Funding

Medical Research Council MR/T032251/1Medical Research Council MR/X503113/1
6 · The paper itself

Abstract

The development of vascular networks in microfluidic chips is crucial for the long-term culture of three-dimensional cell aggregates such as spheroids, organoids, tumoroids, or tissue explants. Despite rapid advancement in microvascular network systems and organoid technologies, vascularizing organoids-on-chips remains a challenge in tissue engineering. Most existing microfluidic devices poorly reflect the complexity of in vivo flows and require complex technical set-ups. Considering these constraints, we develop a platform to establish and monitor the formation of endothelial networks around mesenchymal and pancreatic islet spheroids, as well as blood vessel organoids generated from pluripotent stem cells, cultured for up to 30 days on-chip. We show that these networks establish functional connections with the endothelium-rich spheroids and vascular organoids, as they successfully provide intravascular perfusion to these structures. We find that organoid growth, maturation, and function are enhanced when cultured on-chip using our vascularization method. This microphysiological system represents a viable organ-on-chip model to vascularize diverse biological 3D tissues and sets the stage to establish organoid perfusions using advanced microfluidics.

Indexed as

Islets of LangerhansMicrofluidicsEndotheliumOrganoidsTissue Engineering

Identifiers

PMID38365780
PMCPMC10873332
OpenAlexW4391010423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.